Page 124 - Prostate News Today

Salvages manchester united a point in the champions league against atalanta. good morning. its a chilly start and prostate for some of us with some patchy fog and then it will be another day of sunshine and showers, another day of sunshine and showers, a lot of their showers on the coast, eight feet making it inland and breezy than yesterday. i will have all the details later. its wednesday 3rd of november. our top story: a four—year—old girl who went missing from a remote australian campsit...

In this interview, News-Medical talks to Dr. Simon Chowdhury and Laetitia Guilloux about the current state of prostate cancer, it's prevalence, treatment options and its future.

MELBOURNE, Australia, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved

The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center.

Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. Findings from the study were published in Cancer Epidemiology, Biomarkers & Prevention.

New research shows that testosterone promotes melanoma proliferation by activating a newly recognized nonclassical testosterone receptor in melanoma cells called ZIP9 (encoded by the SLC39A9 gene), a zinc transporter that is not intentionally targeted by any available therapeutics but is widely expressed in human melanoma.

Using fewer-;but higher-;doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.

A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.

Researchers believe targeted annual screening from the age of 40 could lead to earlier diagnosis and treatment of prostate cancer.

SENSEI Achieved 100% Detection of Sentinel Lymph Nodes in Prostate Cancer Surgery and Detected More Sentinel Nodes than a Conventional Gamma Probe CHESHAM, England and CAMBRIDGE, Mass.